Antibody-Drug Conjugates Extend Survival in Triple-Negative Breast Cancer, Meta-Analysis Finds
A systematic review and meta-analysis of six studies covering 2,479 patients found that antibody-drug conjugates significantly improved progression-free and overall ...
